FAC MEDICINA
Centro
AstraZeneca (United Kingdom)
Cambridge, Reino UnidoPublicaciones en colaboración con investigadores/as de AstraZeneca (United Kingdom) (8)
2024
-
Clinical Characteristics and Incidence of Hemorrhagic Complications in Patients Taking Factor Xa Inhibitors in Spain: A Long-Term Observational Study
Journal of Clinical Medicine, Vol. 13, Núm. 6
-
Clinical and Economic Consequences of a First Major Bleeding Event in Patients Treated with Direct Factor Xa Inhibitors in Spain: A Long-Term Observational Study
Journal of Clinical Medicine, Vol. 13, Núm. 14
-
Lack of awareness of systemic lupus erythematosus and its consequences in a cohort of moderate and severe patients in Spain: The LupusVoice study
Lupus, Vol. 33, Núm. 7, pp. 663-674
2018
-
A computational framework for complex disease stratification from multiple large-scale datasets
BMC Systems Biology, Vol. 12, Núm. 1
2017
-
Next-generation sequencing and FISH studies reveal the appearance of gene mutations and chromosomal abnormalities in hematopoietic progenitors in chronic lymphocytic leukemia
Journal of Hematology and Oncology, Vol. 10, Núm. 1
-
U-BIOPRED clinical adult asthma clusters linked to a subset of sputum omics
Journal of Allergy and Clinical Immunology, Vol. 139, Núm. 6, pp. 1797-1807
2008
-
A 12-month, open-label, comparative study of quetiapine and risperidone in the acute and long-term treatment of schizophrenia
International Clinical Psychopharmacology, Vol. 23, Núm. 3, pp. 138-149
2003
-
A comparison of primary care physicians and pneumologists in the management of asthma in Spain: ASES study
Respiratory Medicine, Vol. 97, Núm. 8, pp. 872-881